EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer

Alina Vrieling iD, Linnea T Olsson iD, Guyon Kleuters, Jake S F Maurits iD, Katja Aben iD, J P Michiel Sedelaar iD, Helena Furberg iD, Lambertus A L M Kiemeney iD

Cancer Causes & Control · 2025

DOI: 10.1007/s10552-024-01957-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, 2025. Verfasst von Alina Vrieling und 7 weiteren Autor:innen. Beteiligte Einrichtung: IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands. Alina.Vrieling@radboudumc.nl. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Obesity, Body-Weight Trajectory. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, KWF Kankerbestrijding, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Obesity in mid-life is a well-established risk factor for developing renal cell carcinoma (RCC); however, patients with RCC who are obese at the time of diagnosis have more favorable survival outcomes. To get better insight into the obesity paradox and determine the extent to which weight around diagnosis is stable, we examined pre- and post-diagnosis weight changes in patients with localized RCC.

Methods

We included 334 patients with localized RCC from the prospective cohort ReLife who self-reported body weight at multiple time points ranging from 2 years before to 2 years after diagnosis. Multivariable linear mixed-effects regression models were used to compare weight at each timepoint to weight at diagnosis for the overall study population, as well as stratified by BMI at diagnosis, tumor stage, and tumor grade.

Results

Most patients were classified as overweight (38.3%) or obese (29.6%) at diagnosis. Overall, patients experienced on average 1.45 kg (95% confidence interval (CI) 0.84, 2.06) weight loss in the 2 years before diagnosis. Pre-diagnosis weight loss was higher in patients who were non-obese at diagnosis, and who presented with higher tumor stage and grade. On average, pre-diagnosis weight loss was at least partially regained within two years after diagnosis.

Conclusion

Patients who were non-obese and patients with higher stage and grade tumors had higher pre-diagnosis weight loss, which was at least partially regained after treatment. These patterns suggest there are subgroups of patients with localized RCC who experience disease-related weight loss, which could contribute to the obesity paradox.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsObesityBody-Weight TrajectoryHumansFemaleMaleMiddle AgedProspective StudiesAgedBody Mass IndexWeight LossAdultRisk Factors

Stichwörter der Autor:innen

Body weight changesCancer survivorsCarcinomaObesity paradoxRenal cell

Autor:innen und Institutionen

  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands. Alina.Vrieling@radboudumc.nl.
  • Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Alina Vrieling, Linnea T Olsson, Jake S F Maurits, Katja Aben, J P Michiel Sedelaar, Helena Furberg, Lambertus A L M Kiemeney

Förderung

  • NCI NIH HHS
  • KWF Kankerbestrijding
  • NIH HHS
  • National Institutes of Health
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Vrieling, A., Olsson, L. T., Kleuters, G., Maurits, J. S. F., Aben, K., Sedelaar, J. P. M., Furberg, H., & Kiemeney, L. A. L. M. (2025). Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer. Cancer Causes & Control. https://doi.org/10.1007/s10552-024-01957-2

Vancouver

Vrieling A, Olsson LT, Kleuters G, Maurits JSF, Aben K, Sedelaar JPM, et al. Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer. Cancer Causes & Control. 2025. doi:10.1007/s10552-024-01957-2

BibTeX
@article{Vrieling2025,
  author = {Vrieling, Alina and Olsson, Linnea T and Kleuters, Guyon and Maurits, Jake S F and Aben, Katja and Sedelaar, J P Michiel and Furberg, Helena and Kiemeney, Lambertus A L M},
  title = {Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer},
  journal = {Cancer Causes & Control},
  year = {2025},
  doi = {10.1007/s10552-024-01957-2}
}
Kostenlos starten →